Piroxicam (20 mg o.d.), ibuprofen (300 mg t.i.d.) or placebo were added to the conventional treatment in three different groups of professional athletes with soft-tissue injuries. The piroxicam-treated group showed, with a once-a-day only administration, a statistically significant better improvement of various subjective and objective signs of functional damage.
Get full access to this article
View all access options for this article.
References
1.
BlazinaM E (1969) Oxyphenbutazone as an adjunct to the conventional treatment of athletic injuries. Clinical Medicine76, 19.
2.
ChiapuzzoA (1979) A comparison of indoprofen and indomethacin in the supportive treatment of soft-tissue injuries in football players: a pilot study. Journal of International Medical Research7, 57.
3.
FitchK DGrayS D (1974) Indomethacin in soft-tissue sports injuries. Medical Journal of Australia1, 260.
4.
HuskissonE CBerryHStreetF GMedhurstH E (1973) Indomethacin for soft-tissue injuries. A double-blind study in football players. Rheumatology and Rehabilitation12, 159.
5.
MuckleD S (1974) Comparative study of ibuprofen and aspirin in soft-tissue injuries. Rheumatology and Rehabilitation13, 141.
6.
Van MarionW F (1973) Indomethacin in the treatment of soft-tissue lesions. A double-blind trial against placebo. Journal of International Medical Research1, 151.
7.
WisemanE H (1978) Review of preclinical studies with piroxicam: pharmacology, pharmacokinetics and toxicology. In: Piroxicam. Royal Society of Medicine, I.C.S.S. No. 1, London, p 11–23.
8.
WisemanE HChangY HLombardinoJ G (1976) Piroxicam, a novel anti-inflammatory agent. Arzneimittel Forschung26, 1300.
